A/Prof Nada Hamad (BSc MSc Forensic (hons) MBBS (hons) FRACP FRCPA SpeCetClinRes(Onc)) is a senior staff specialist in bone marrow transplant (BMT) and cellular therapies. She is a clinical and laboratory haematologist at St Vincent’s hospital in Sydney and the director of the haematology clinical trials unit. She has two post-graduate fellowships subspecialising in BMT and lymphoma from the Princess Margaret Cancer Centre in Toronto, Canada, through the University of Toronto. She has a strong interest in clinical trials and drug development and has a specialist certificate in Clinical Research from the University of Melbourne. Her research focus is in haematological malignancy, incorporating novel agents and diagnostics and bone marrow transplantation and cellular therapies. She has been principle investigator on over 40 studies. She is an international and national leader in the field of haematological malignancy, BMT and cellular therapies. She has developed strong international and national collaborative research networks in BMT research.
A/Prof Hamad is president of the Australia and New Zealand Transplant and Cellular Therapies, Chair of the Australasian Bone Marrow Transplant Recipient Registry, Chair of the Agency for Clinical Innovation NSW BMT network, Chair of the Australasian Leukaemia and Lymphoma Group (ALLG) BMT and cellular therapies working group and Scientific Advisory Committee member. She is a leader in equity, diversity and inclusion in medicine and is the Deputy Co-Chair of the UNSW Medicine Equity Diversity and Inclusion Committee amongst other leadership roles in this field.
She also led and developed Australasian management and vaccination guidelines and advocacy initiatives for haematological malignancies during the COVID pandemic.